# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!


Pituitary cancer

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 52 results.
PITUItary Carcinoma or Aggressive Tumors REgistry -Lyon
Status: Recruiting
Last Changed: Aug 03, 2016
First Received: Aug 03, 2016
Disease(s): Pituitary Tumor
Locations: Groupement Hospitalier Est, Lyon, France, Bron, France
Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors
Status: Recruiting
Last Changed: Jun 02, 2020
First Received: Aug 02, 2019
Disease(s): Pituitary, Pituitary Tumor, Pituitary Carcinoma, Pituitary Cancer
Intervention(s): Ipilimumab, Nivolumab, Nivolumab
Locations: Memoral Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
Memoral Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
Memorial Sloan Kettering Cancer Center @ Commack (Limited Protocol Activities), Commack, New York, United States
Memoral Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
... and 3 other locations.
International PPB/DICER1 Registry
Status: Recruiting
Last Changed: Aug 19, 2019
First Received: Dec 22, 2017
Disease(s): Pleuropulmonary Blastoma, Sertoli-Leydig Cell Tumor, DICER1 Syndrome, Cystic Nephroma, Wilms Tumor, Pineoblastoma, Renal Sarcoma, Nodular Hyperplasia of Thyroid, Nasal Chondromesenchymal Hamartoma, Ciliary Body Medulloepithelioma, Neuroblastoma, Pituitary Cancer, Embryonal Rhabdomyosarcoma
Locations: Children's Minnesota, Minneapolis, Minnesota, United States
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Recruiting
Last Changed: Oct 19, 2020
First Received: Jul 15, 2016
Disease(s): Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortex Carcinoma, Adrenal Gland Pheochromocytoma, Anal Canal Neuroendocrine Carcinoma, Anal Canal Undifferentiated Carcinoma, Angiosarcoma, Apocrine Neoplasm, Appendix Mucinous Adenocarcinoma, Bartholin Gland Transitional Cell Carcinoma, Basal Cell Carcinoma, Bladder Adenocarcinoma, Cervical Adenocarcinoma, Cervical Clear Cell Adenocarcinoma, Cholangiocarcinoma, Chordoma, Colorectal Squamous Cell Carcinoma, Desmoid-Type Fibromatosis, Endometrial Transitional Cell Carcinoma, Endometrioid Adenocarcinoma, Esophageal Neuroendocrine Carcinoma, Esophageal Undifferentiated Carcinoma, Extrahepatic Bile Duct Carcinoma, Extramammary Paget Disease, Fallopian Tube Adenocarcinoma, Fallopian Tube Transitional Cell Carcinoma, Fibromyxoid Tumor, Gallbladder Carcinoma, Gastric Neuroendocrine Carcinoma, Gastric Squamous Cell Carcinoma, Gastric Undifferentiated Carcinoma, Gastrointestinal Stromal Tumor, Gestational Trophoblastic Tumor, Giant Cell Carcinoma, Intestinal Neuroendocrine Carcinoma, Intrahepatic Cholangiocarcinoma, Lung Carcinoid Tumor, Lung Sarcomatoid Carcinoma, Major Salivary Gland Carcinoma, Malignant Odontogenic Neoplasm, Malignant Peripheral Nerve Sheath Tumor, Malignant Solid Neoplasm, Malignant Testicular Sex Cord-Stromal Tumor, Metaplastic Breast Carcinoma, Metastatic Malignant Neoplasm of Unknown Primary, Minimally Invasive Lung Adenocarcinoma, Mixed Mesodermal (Mullerian) Tumor, Mucinous Adenocarcinoma, Mucinous Cystadenocarcinoma, Nasal Cavity Adenocarcinoma, Nasal Cavity Carcinoma, Nasopharyngeal Carcinoma, Nasopharyngeal Papillary Adenocarcinoma, Nasopharyngeal Undifferentiated Carcinoma, Oral Cavity Carcinoma, Oropharyngeal Undifferentiated Carcinoma, Ovarian Adenocarcinoma, Ovarian Germ Cell Tumor, Ovarian Mucinous Adenocarcinoma, Ovarian Squamous Cell Carcinoma, Ovarian Transitional Cell Carcinoma, Pancreatic Acinar Cell Carcinoma, Pancreatic Neuroendocrine Carcinoma, Paraganglioma, Paranasal Sinus Adenocarcinoma, Paranasal Sinus Carcinoma, Parathyroid Gland Carcinoma, PEComa, Peritoneal Mesothelioma, Pituitary Gland Carcinoma, Placental Choriocarcinoma, Primary Peritoneal High Grade Serous Adenocarcinoma, Pseudomyxoma Peritonei, Rare Disorder, Scrotal Squamous Cell Carcinoma, Seminal Vesicle Adenocarcinoma, Seminoma, Serous Cystadenocarcinoma, Small Intestinal Adenocarcinoma, Small Intestinal Squamous Cell Carcinoma, Spindle Cell Neoplasm, Squamous Cell Carcinoma of the Penis, Teratoma With Somatic-Type Malignancy, Testicular Non-Seminomatous Germ Cell Tumor, Thyroid Gland Carcinoma, Tracheal Carcinoma, Transitional Cell Carcinoma, Ureter Adenocarcinoma, Ureter Squamous Cell Carcinoma, Urethral Adenocarcinoma, Urethral Squamous Cell Carcinoma, Vaginal Adenocarcinoma, Vaginal Squamous Cell Carcinoma, Not Otherwise Specified, Vulvar Carcinoma
Intervention(s): Biospecimen Collection, Ipilimumab, Nivolumab
Locations: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
University of South Alabama Mitchell Cancer Institute, Mobile, Alabama, United States
Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States
Anchorage Radiation Therapy Center, Anchorage, Alaska, United States
Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States
... and 938 other locations.
Pituitary Tumor Surveillance: Pathogenic Correlation
Status: Recruiting
Last Changed: Jan 31, 2019
First Received: Jan 23, 2008
Disease(s): Pituitary Tumor
Locations: Cedars-Sinai Medical Center, Pituitary Center, Los Angeles, California, United States
Ga-68-DOTATOC -PET in the Management of Pituitary Tumours
Status: Recruiting
Last Changed: Nov 02, 2018
First Received: Apr 17, 2015
Disease(s): Pituitary Tumours
Intervention(s): Gallium-68 DOTATOC PET
Locations: Center of Endocrinology and Metabolism, Sahlgrenska university Hospital, Göteborg, Sweden
Nasal Irrigation Apply in Patients After Transsphenoidal Pituitary Tumor Resection
Status: Recruiting
Last Changed: May 20, 2019
First Received: May 01, 2019
Disease(s): Pituitary Tumor
Intervention(s): nasal irrigation
Locations: The Second Affiliated hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Extended Support for Persons With Pituitary Tumours After Surgery
Status: Recruiting
Last Changed: Apr 29, 2019
First Received: Apr 25, 2019
Disease(s): Pituitary Tumor Benign, Surgery
Intervention(s): person-centred practice
Locations: Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
Nasal Packing Following Endoscopic Endonasal Pituitary Resection
Status: Recruiting
Last Changed: May 28, 2020
First Received: Sep 19, 2018
Disease(s): Pituitary Tumor
Intervention(s): No nasal packing., Nasal Packing
Locations: The Ottawa Hospital, Ottawa, Ontario, Canada
Feasibility of Endosphenoidal Coil Placement for Imaging of the Sella During Transsphenoidal Surgery
Status: Recruiting
Last Changed: Sep 16, 2020
First Received: Sep 19, 2018
Disease(s): Pituitary Neoplasm
Intervention(s): ESC
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland, United States